Evidence map›Paper›PMID 42259818›Full record

ArticleNature communications2026

Switchable annulation paths to diverse N-bridged bicyclic scaffolds via ligand-directed dicarbonylation.

Yu-Kun Liu, Peng Yang, Le-Cheng Wang, Zhi-Peng Bao, Xiao-Feng Wu

Abstract read
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Yu-Kun LiuLeibniz-Institut für Katalyse e. V., Rostock, Germany.
Peng YangLeibniz-Institut für Katalyse e. V., Rostock, Germany.
Le-Cheng WangLeibniz-Institut für Katalyse e. V., Rostock, Germany.
Zhi-Peng BaoLeibniz-Institut für Katalyse e. V., Rostock, Germany.
Xiao-Feng WuLeibniz-Institut für Katalyse e. V., Rostock, Germany. xiao-feng.wu@catalysis.de.ORCID http://orcid.org/0000-0001-6622-3328

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

N-Bridged bicyclic scaffolds bearing 3-azabicyclo[3.2.0]heptane and 3-azabicyclo[3.1.1]heptane cores have emerged as privileged bioisosteres of piperidine and meta-substituted pyridine, offering enhanced conformational rigidity and improved pharmacokinetic profiles. However, existing synthetic approaches are typically restricted to single scaffolds, limiting scaffold diversity. Here, we report a ligand-controlled, palladium-catalyzed tandem dicarbonylation of readily available cyclobutenols and amines, enabling divergent access to both 3-azabicyclo[3.2.0]heptane and 3-azabicyclo[3.1.1]heptane scaffolds from the same substrate. This strategy overcomes key challenges associated with strained-ring systems-including ring-opening side reactions and complex regio-, stereo-, and diastereoselective control-through fine-tuning of the catalyst environment. The method demonstrates excellent selectivity, broad substrate compatibility, and operational simplicity, accommodating 20 derivatives of bioactive molecules. This work provides a modular and general platform for the synthesis of structurally distinct N-bridged heterobicycles, addressing a critical gap in the development of bioisosteric nitrogen-containing scaffolds.

Identifiers

PMID42259818
PMCPMC13247086

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.